Found 291 articles for: "General Medical Dermatology"
Assessing the Landscape of AI-Powered Patient Documentation in Dermatology
January 2025 | Volume 24 | Issue 1 | Journal Article | 64 | Copyright © January 2025
Background: The prevalence of burnout among United States (US) dermatologists has surged, reaching 49% in 2023, with a growing volume of bureaucratic tasks (eg, charting, paperwo...
Read MorePharmacological Complications in Ocular Dermatology: A Review and Update
December 2024 | Volume 23 | Issue 12 | Original Article | 1108 | Copyright © December 2024
Many dermatologic medications have the potential to induce ocular complications. Traditional medications, including corticosteroids, retinoids, antibiotics, antihistamines, and immunosuppressants...
Read MoreThe Role of JAK Inhibitors in the Treatment of Cutaneous Lupus Erythematosus: A Review
December 2024 | Volume 23 | Issue 12 | Original Article | 1100 | Copyright © December 2024
Cutaneous lupus erythematosus (CLE), a manifestation of the chronic autoimmune disease lupus erythematosus (LE), showcases diverse clinical, immunologic, and histologic attributes. CLE can be fur...
Read MoreInternational Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting
December 2024 | Volume 23 | Issue 12 | Original Article | 1114 | Copyright © December 2024
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization whose mission is to improve the availability of evidence-based, consensus-driven outco...
Read MoreInjectable Minoxidil for Hair Loss Disorders: A Systematic Review
December 2024 | Volume 23 | Issue 12 | Original Article | 1084 | Copyright © December 2024
Background: Minoxidil is a frequently prescribed medication for hair loss. Although topical and oral minoxidil is widely established for treating hair loss by dermatologists, the...
Read MorePractical Update on Treatment of Oral Candidiasis
December 2024 | Volume 23 | Issue 12 | Features | e186 | Copyright © December 2024
Dermatologists are likely to periodically encounter candidiasis in clinical practice, especially given the increased risk with the use of new broad-spectrum IL-17 blocking psoriasis agents such a...
Read MoreCutaneous Collagenous Vasculopathy Treated With Pulsed Dye Laser: A Case Series and Literature Review
December 2024 | Volume 23 | Issue 12 | Case Reports | 1121 | Copyright © December 2024
Cutaneous collagenous vasculopathy (CCV) is an underreported cutaneous microangiopathy that primarily involves the lower extremities. Optimal treatment of CCV has not been well-defined, which may...
Read MoreLight and Laser-Imaging Detection and Ranging (LiDAR) in Dermatology: A New Dimension for Digital Healthcare
December 2024 | Volume 23 | Issue 12 | Editorials | e197 | Copyright © December 2024
An Update on the Off-Label Uses of Low-Dose Naltrexone in Dermatology
December 2024 | Volume 23 | Issue 12 | Features | 1127 | Copyright © December 2024
Social Media and the Dermatologist
December 2024 | Volume 23 | Issue 12 | Features | 1125 | Copyright © December 2024
Evaluating Anti-Inflammatory Potential of Platelet-Rich Plasma in Scarring Alopecia: A Systematic Review
December 2024 | Volume 23 | Issue 12 | Original Article | 1076 | Copyright © December 2024
Scarring alopecia, also known as cicatricial alopecia, is a group of hair loss disorders characterized by inflammatory destruction of hair follicles, leading to hair loss and scar tissue formatio...
Read MoreThe Efficacy of Intense Pulsed Light and Laser Hair Removal in Hidradenitis Suppurativa Treatment
November 2024 | Volume 23 | Issue 11 | Original Article | 926 | Copyright © November 2024
Background: Hidradenitis suppurativa (HS) is a multifactorial disease that presents with chronic cycles of inflammation, healing, and scarring and that elicits a profoundly negat...
Read MoreNew Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model
November 2024 | Volume 23 | Issue 11 | Original Article | 953 | Copyright © November 2024
The greatest risk factor for skin cancer is exposure to ultraviolet (UV) rays of the sun. Among the three types of solar radiation (UVA, UVB, UVC), UVB rays are most commonly associated with skin...
Read MoreAttitudes on, Practices, and Recommendations for Visible Light Protection Amongst Dermatology Practitioners
November 2024 | Volume 23 | Issue 11 | Original Article | 965 | Copyright © November 2024
Background: Iron oxides, antioxidants, and pigmentary titanium dioxide are sunscreen additive ingredients that enhance visible light protection, reduce associated hyperpigme...
Read MoreThe Clinical Efficacy and Tolerability of a Novel Retinaldehyde Serum with Firming Peptides to Improve Skin Texture and Signs of Photoaging
November 2024 | Volume 23 | Issue 11 | Original Article | 992 | Copyright © November 2024
Retinoids are derivatives of vitamin A prominently used in cosmeceuticals to reverse signs of photoaging. Retinaldehyde (retinal) is 10x more bioavailable than retinol and is gaining tra...
Read MoreIsobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies
November 2024 | Volume 23 | Issue 11 | Original Article | 986 | Copyright © November 2024
Background: Tyrosinase is the rate-limiting enzyme of melanogenesis and thus an ideal inhibitory target for treating hyperpigmentation. There are many commercially available tyro...
Read MoreBiologic Use During Pregnancy and Breastfeeding in Dermatology: An Evidence-Based Review
November 2024 | Volume 23 | Issue 11 | Original Article | 1010 | Copyright © November 2024
Biologic medications have revolutionized the treatment of many dermatologic conditions. However, their use during pregnancy and breastfeeding is a subject of ongoing concern due to limited data o...
Read MoreA Single-Center, Open-Label, Prospective Study of a 589/1319 nm Dual Wavelength Laser for the Treatment of Facial Hyperpigmentation
November 2024 | Volume 23 | Issue 11 | Original Article | 943 | Copyright © November 2024
Background: Facial hyperpigmentation, characterized by the excessive production of melanin in the skin, is a prevalent dermatological concern affecting individuals of various eth...
Read MoreFrom CO2 to Er:YAG: A Comprehensive Review of Laser Treatments for Rhinophyma
November 2024 | Volume 23 | Issue 11 | Original Article | 932 | Copyright © November 2024
Background: Rhinophyma, a benign condition resulting in nasal sebaceous tissue hypertrophy, predominantly affects Caucasian males. There are numerous surgical and medical treatme...
Read MorePrimary Hyperhidrosis and Sensitive Skin: Exploring the Link with Predictive Machine Learning-Based Classification Models
October 2024 | Volume 23 | Issue 10 | Original Article | 882 | Copyright © October 2024
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
